| Muscular Atrophy |
1 |
0.69 |
| Amyotrophic Lateral Sclerosis |
0 |
0.68 |
| Food and Drug Administration (FDA) |
0 |
0.68 |
| Neurodegenerative Diseases |
0 |
0.48 |
| Healthcare and Medical Technology |
0 |
0.21 |
| Clinical Research |
0 |
0.2 |
| Drug Development |
0 |
0.2 |
| Face |
0 |
0.07 |
| Pathogenesis |
0 |
0.07 |
| Quality of Life |
0 |
0.07 |